From pharmaceuticals to nutraceuticals: Bridging disease prevention and management P Daliu, A Santini, E Novellino Expert Review of Clinical Pharmacology 12 (1), 1-7, 2019 | 251 | 2019 |
Abelmoschus esculentus (L.): Bioactive Components’ Beneficial Properties—Focused on Antidiabetic Role—For Sustainable Health Applications A Durazzo, M Lucarini, E Novellino, EB Souto, P Daliu, A Santini Molecules 24 (1), 38, 2018 | 167 | 2018 |
A decade of nutraceutical patents: where are we now in 2018? P Daliu, A Santini, E Novellino Expert opinion on therapeutic patents 28 (12), 875-882, 2018 | 151 | 2018 |
Colon bioaccessibility and antioxidant activity of white, green and black tea polyphenols extract after in vitro simulated gastrointestinal digestion G Annunziata, M Maisto, C Schisano, R Ciampaglia, P Daliu, V Narciso, ... Nutrients 10 (11), 1711, 2018 | 102 | 2018 |
Astaxanthin production by Xanthophyllomyces dendrorhous growing on a low cost substrate T Gervasi, A Santini, P Daliu, AZM Salem, C Gervasi, V Pellizzeri, ... Agroforestry Systems 94, 1229-1234, 2020 | 54 | 2020 |
Abscisic acid identification in Okra, Abelmoschus esculentus L. (Moench): perspective nutraceutical use for the treatment of diabetes P Daliu, G Annunziata, GC Tenore, A Santini Natural product research 34 (1), 3-9, 2020 | 54 | 2020 |
Targeting metabolic diseases: the role of nutraceuticals in modulating oxidative stress and inflammation A Dama, K Shpati, P Daliu, S Dumur, E Gorica, A Santini Nutrients 16 (4), 507, 2024 | 35 | 2024 |
Fruit‐based juices: Focus on antioxidant properties—Study approach and update A Durazzo, M Lucarini, E Novellino, P Daliu, A Santini Phytotherapy Research 33 (7), 1754-1769, 2019 | 35 | 2019 |
Roli i antioxidantëve në menazhimin e faktorëve proatherogjen dhe protrombotik P Daliu, G Annunziata, F Guerra Optime, 134-138, 2024 | | 2024 |
Okra (Abelmoschus esculentus L.) Derived Abscisic Acid and Use in Diabetes P Daliu, A Santini Ancient and Traditional Foods, Plants, Herbs and Spices used in Diabetes …, 2023 | | 2023 |
Acidi abscisik molekula dhe hormoni më i ri në parandalimin e diabetit melitus. P Daliu, E Schiano, G Anunzziata Optime, 55-62, 2022 | | 2022 |
Oleuropeina një agjent i ri terapeutik në parandalimin e diabetit tipi 2. Raportimi i një studimi klinik P Daliu, G Anunzziata Optime, 49-55, 2022 | | 2022 |
Përdorimi i fermenteve laktike si nje qasje e re në mbrojtjen e përbërësve natyralë dhe eleminimin e efekteve anësore në shëndetin e njeriut P Daliu, R Ciampaglia, A Santini Optime, 20-35, 2021 | | 2021 |
Ekstraktet e bimës Kudzu (Pueraria officinalis) dhe derivati gjysmë sintetik i saj cv 10216, si terapia më e re klinike konkurruese e disulfiramit në procesin e lënies dhe … P Daliu Optime, 76-81, 2016 | | 2016 |
XXXIII CYCLE E Novellino, A Santini, MV D’Auria, P Daliu | | |